glp 1 gastroparesis treatment GLP-1 Risk: What Patients Need to Know GLP-1 Gastroparesis Lawsuit: Stomach Paralysis

Research context Community subcutaneous planning Amount or duration 300500 mcg per day Evidence level Anecdotal community standard Research context Published human trials Amount or duration Route and dose varied by study Evidence level Published research Research context Approved medical dosage Amount or duration None Evidence level AOD-9604 is not FDA-approved AOD-9604 Reconstitution Guide: How to Mix a 5 mg Vial A 5 mg AOD-9604 vial can be mixed with different amounts of bacteriostatic water

The Cons of Microdosing GLP-1s The reason they dont is that we dont have any data on it, YET

Nusgens BV, Humbert P, Rougier A, et al

C., Cooper-Cox, K

Care 26 , 78 (2025)